B-cell receptor (BCR) specific for HIV-1 BG505 envelope trimer epitopes (BG505 Env-specific BCR)

B-cell receptors (BCRs) specific for HIV-1 BG505 Env trimer epitopes are the primary targets for next-generation HIV vaccine strategies aimed at eliciting broadly neutralizing antibodies (bNAbs). These receptors are membrane-bound immunoglobulins on the surface of B cells that recognize the native-like structure of the BG505 envelope glycoprotein, a clade A strain often used as a model for trimer stability (Sanders et al., 2013, PLOS Pathogens). The goal of targeting these BCRs is to guide the immune system through a process of affinity maturation to produce bNAbs capable of neutralizing diverse HIV-1 strains (Burton & Hangartner, 2016, Annual Review of Immunology). By using stabilized trimers like BG505 SOSIP.664, researchers aim to selectively activate B cells with the potential to target conserved epitopes such as the CD4 binding site or the V1/V2 apex (Jardine et al., 2013, Science). This approach is critical for overcoming the high mutational diversity of HIV-1 and the difficulty of eliciting protective immunity. Successful engagement and maturation of these BCRs are monitored as key indicators of vaccine efficacy in clinical trials (ClinicalTrials.gov, NCT02231697). These BCRs serve as the starting point for germline-targeting immunogens, which are designed to bind specifically to the unmutated precursors of known bNAbs. The interaction between the BG505 trimer and the BCR triggers intracellular signaling pathways that lead to B-cell expansion and differentiation into plasma cells. Ultimately, the therapeutic objective is to establish a memory B-cell population that can respond rapidly to a real HIV-1 infection.

Other names

HIV-1 BG505 Env-specific B-cell receptorBG505 SOSIP-binding BCRAnti-BG505 B-cell receptorBG505-specific BCRHIV-1 envelope-specific B-cell receptor

The mechanism involves the binding of the BG505 Env trimer immunogen to the B-cell receptor, which induces receptor clustering and activates the B-cell signaling cascade. This activation promotes B-cell entry into germinal centers, where they undergo somatic hypermutation and selection for higher affinity to the native-like trimer epitopes (Sanders et al., 2013, PLOS Pathogens; Jardine et al., 2013, Science).